Both in Pharmaceuticals
Rhythm Pharmaceuticals vs Axsome Therapeutics
Over the past year RYTM returned +5.4% and AXSM returned +1.5%; their daily moves had a correlation of 0.28.
RYTM +5.4% AXSM +1.5%Growth of $1, one year, split-adjusted
| Metric | RYTM | AXSM |
|---|---|---|
| Price | $110.68 | $137.00 |
| Market cap | $7.62B | $7.18B |
| Today | +28.04% | −1.87% |
| 1 month | +21.9% | −21.4% |
| 6 months | +14.6% | −38.5% |
| Year to date | +3.4% | −25.0% |
| 1 year | −2.7% | +0.9% |
| Revenue growth (YoY) | +46.9% | +51.9% |
| Gross margin | 87.5% | 93.1% |
| Net margin | −70.7% | −5.0% |
| P/E (TTM) | — | — |
| Price / sales | 31.8× | 8.3× |
| Net cash | $224.8M | $116.6M |
| Dividend yield | — | — |
| Volatility (60d) | 61.5% | 38.0% |
| Short % of float | 17.1% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).